Initial Results of a Phase Ib Study of Ibrutinib in Combination with Obinutuzumab in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
暂无分享,去创建一个
A. LaCasce | M. Davids | D. Fisher | E. Jacobsen | Jennifer R. Brown | J. Abramson | Haesook T. Kim | K. Francoeur | A. Savell | Carlos Santiago-Medero